Impact of nitric oxide on renal hemodynamics and glomerular function: Modulation by atherogenic lipoproteins?

Kidney and Blood Pressure Research

Volumn 19, Issue 1, 1996, Pages 2-15

  Galle, Jan ^a   Wanner, Christoph ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CONTRAST MEDIUM; CYCLOSPORIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RENIN;

ATHEROSCLEROSIS; AUTOREGULATION; DIABETES MELLITUS; ENZYME LOCALIZATION; FEEDBACK SYSTEM; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HUMAN; HYPERTENSION; KIDNEY ARTERY; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TUBULE FUNCTION; NATRIURESIS; NEPHROTOXICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN RELEASE; REVIEW;

EID: 0029847313     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000174040     Document Type: Article

References (180)

1. Inagami T, Narase M, Hoover R: Endothelium as an endocrine organ, Ann Rev Physiol 1995; 57:171-189.
2. Lennan A, Burnett JC Jr.: Intact and altered endothelium in regulation of vasomotion, Circulation !992;86(suppl): 12 19.
3. Liischer TF: The endothelium and cardiovascular disease: A complex relation, N Engl J Med 1994:330:1081-1083.
4. Bassenge E, Heusch G: Endothelial and neuro-humoral control of coronary blood flow in health and disease, Rev Physiol Biochem Pharmacol 1990:116:77-165.
5. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature 1980: 288:373-376.
6. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature 1987;327:524-526.
7. Busse R, Fleming L: Regulation and functional consequences of endothelial nitric oxide formation, Ann Med 1995:27:331-340.
8. Loscalzo J: Nitric oxide and vascular disease, N Engl J Med 1995:333:251-253.
9. Bredt DS, Snyder SH: Nitric oxide: A physiologic messenger molecule, Ann Rev Biochem 1994;63:175-195.
10. Lowcnstein CJ, Dincrman JL, Snyder SH: Nitric oxide: A physiologic messenger, Ann Intern Med 1994:120:227-237.
11. Moncada S, Higgs A: Mechanisms of disease: The γ-arginine-nitric oxide pathway, N Engl J Med 1993:329:2002-2012.
12. Ignarro LJ: Biosynthesis and metabolism of endothelium-derived nitric oxide, Ann Rev Pharmacol Toxicol 1990:30:535-560.
13. Flavahan NA: Atherosclerosis or lipoprotein-induced endothelial dysfunction: Potential mechanisms underlying reduction in EDRF nitric oxide activity, Circulation 1992:85:1927-1938.
14. Noll G, Liischer TF: Influence of lipoproteins on endothelial function, Thromb Res 1994; 74(suppl 1):S45-S54.
15. Förstermann U, Closs El, Pollock JS, Nakanc M, Schwarz P, Gath 1. Kleinert II: Nitric oxide synthase isozymes: Characterization, purification, molecular cloning, and functions, Hypertension 1994:23:1121-1131.
16. Mayer B, John M, Böhme E: Purification of a Ca2/calmodulin-dependent nitric oxide synthase from porcine cerebellum, Cofactor role of tetrahydrobiopterin, FEBS Lett 1990:277:215-219.
17. Schmidt HHHW, Pollock JS, Nakanc M, Gorsky LD, Förstermann U, Murad F: Purification of a soluble isoform of guanylyl cyclase-activa-ting-factor synthase, Proc Natl Acad Sei USA 1991:88:365-369.
18. Radomski MW, Palmer RMJ, Moncada S: Ehe role of nitric oxide and cGMP in platelet adhesion to vascular endothelium, Biochem Biophys Res Commun 1987:148:1482-1489.
19. Tracey WR, Pollock JS, Murad F, Nakanc M, Förstermann U: Identification of an endothelial-like type III NO synthase in LLC-PK, kidney epithelial cells, Am J Physiol 1994;266:C22-C28.
20. Busse R, Miilsch A: Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin, FEBS Lett 1990:265:133-136.
21. Pollock JS, Förstermann U, Mitchell JA, Warner TD, Schmidt HHHW, Nakanc M, Murad F: Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells, Proc Natl Acad Sei USA 1991:88: 10480-10484.
22. Xie QW, Clio IIJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding AH, Troso T, Nathan C: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages, Science 1992:256:225-228.
23. Fleming I, Gray GA, Schott C, Stoclet JC: Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells, Eur J Pharmacol 1991:200:375-376.
24. Iida S, Ohshima H, Oguchi S, Hata T, Suzuki II, Kawasaki II, Esumi H: Identification of inducible calmodulin-dependent nitric oxide synthase in the liver of rats, J Biol Chem 1992:267: 25385-25388.
25. Geller DA, Nussler AK, Di Silvio M, Lowen-stcin CJ, Shapiro RA, Wang SC, Simmons RE, BilliarTR: Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes, Proc Natl Acad Sei USA 1993;90:522-526.
26. Charles IG, Palmer RMJ, Hickery MS, Bavliss MT, Chubb AP, Hall VS, Moss DW Moncada S: Cloning, characterization and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte, Proc Natl Acad Sei USA 1993:90:11419-11423.
27. Smith JA, Radomski MW, Schulz R, Moncada S, Lewis MJ: Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase, BrJ Pharmacol 1993:108: 1107-1110.
28. Shultz PJ, Archer SL, Rosenberg ME: Inducible nitric oxide synthase mRNA and activity in glomerular mesangial cells, Kidney Int 1994: 46:683-689.
29. Kunz D, Mühl H, Walkcr G, Pfeilschifter J: Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells, Proc Natl Acad Sei USA 1994;91:5387-5391.
30. Stuehr DJ, Nathan CF: Nitric oxide A macrophage product responsible forcytostasis and respiratory inhibition in tumor target cells, J Exp Med 1989;169:1543-1555.
31. Petros A, Bennett D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock, Lancet 1991:338: 1557-1558.
32. Bachmann S, Mundel P: Nitric oxide in the kidney: Synthesis, localization, and function, Am J Kidney Dis 1994:24:112-129.
33. Bachmann S, Bosse HM, Mundel P: Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney, Am J Physiol 1995;268:F885-E898.
34. Mundel P, Bachmann S, Bader M, Fischer A, Kummer W, Mayer B, Kriz W: Expression of nitric oxide synthase in kidney macula densa cells, Kidney Int 1992:42:1017-1019.
35. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, Schmidt HIIHW: Nitric oxide synthase in macula densa regulates glomerular capifary pressure, Proc Natl Acad Sci USA 1992:89:11993-11997.
36. Schmidt HHHW, Gagne GD, Nakanc M, Pollock JS, Miller ME, Murad F: Mapping of neural nitrix oxide synthase in the rat suggests frequent co-localization with NADPII diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergie signal transduction, J Histochem Cytochem 1992;40: 1439-1456.
37. Tojo A, Gross SS, Li Zhang C, fisher G, Schmidt HHHW, Wilcox CS, Madsen KM: Im-munocytochemical localization of distinct isoforms of nitric oxide synthase in the juxtaglomerular apparatus of normal rat kidney, J Am Soc Nephrol 1994:4:1438-1447.
38. Inrig JD, Roman RJ: Nitric oxide modulates vascular tone in preglomerular arterioles, Hypertension 1992:19:770-774.
39. Ito S, Johnson CS, Carretero O: Modulation of angiotensin ll-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole, J Clin Invest 1991;87:1656-1663.
40. Rhaleb NE, Dion S, Barabe J, Rouissi N, Jukic D, Drapeau G, Regoli D: Receptors for kinins in isolated arterial vessels of dogs, Eur J Pharmacol 1989;162:419-427.
41. Luscher TF, Diederieh D, Weber E, Vanhoutte PM, Buhler FR: Endothelium-dependent responses in carotid and renal arteries of normo-tensive and hypertensive rats, Hypertension 1988:11:573-578.
42. Beierwaltes WH, Sigmon DH, Carretero OA: Endothelium modulates renal blood flow but not autoregulation, Am,1 Physiol 1992:262: F943-F949.
43. Gallc J, Schcnck I, Schollmeycr P, Wanner C: Cyclosporine and oxidized lipoproteins affect vascular reactivity: Influence of the endothelium, Hypertension 1993:21:315-321.
44. Sigmon DH, Carretero OA, Beierwaltes WH: Renal versus femoral hemodynamic response to endothelium-derived relaxing factor synthesis inhibition, J Vase Res 1993:30:218-223.
45. Ohishi K, Carmines PK, Inseho EW Navar EG: EDRF-angiolensin II interactions in rat juxta-mcdullary afferent and efferent arterioles, AM J Physiol 1992;263:F900-F906.
46. Ujiie K, Yuen J, Hogarth L, Danziger R, Star RA: Localization and regulation of endothelial NO synthase niRNA expression in rat kidney, Am J Physiol 1W4;267: F296-F302.
47. Marsden PA, Brock TA, Ballcrmann BJ: Glomerular endothelial ceils respond to calcium-mobilizing agonists with release of edrf, Am J Physiol 1990;258:F1295-F1303.
48. Markewitz BA, Michael JR, Kohan DE: Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells, J Clin Invest 1693: 91:2138-2143.
49. Galle J, Sehini V, Stunz P, Wanner C, Scholl-mcyer P: Interleukin-lb induces the formation of nitric oxide in isolated juxtaglomerular cells: Influence on renin secretion, Nephrol Dial Transplant 1995:10:191-197.
50. Pfeilschifter J, Rob P, Miilsch A, Fandrey J, Vosbeck K, Busse R: Interleukin lbeta and tumour necrosis factor alpha induce a macrophage-type of nitric oxide synthase in rat renal ntesangial cells, Fur, I Biochcm 1992:203:251-255.
51. Shultz PJ, Tayeh MA, Marietta MA, Raij L: Synthesis and action of nitric oxide in rat glomerular ntesangial cells, Am J Physiol 1991; 26L :F600-F606.
52. Palmer RMJ, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from /,-arginine, Nature 1988:333:664-666.
53. Rapoport RM, Murad F: Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP, Circ Res 1983;52:352-357.
54. Ignarro LJ, Byms RE, Wood KS: Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein, Circ Res 1987: 60:82-92.
55. Lahcra V, Salom MG, Fiksenolsen MJ, Raij L, Romero JC: Effects of N-G-monomethyl-i-ar-ginine and ¿-arginine on acetylcholine renal response, Hypertension 1990:15:659-663.
56. Luscher I F, Boch HA, Yang ZH, Dicderich D: Endothelium-derived relaxing and contracting factors: Perspectives in nephrology, Kidney Int 1991:39:575-590.
57. King AJ, Brenner BM: Endothelium-derived vasoactive factors and the renal vasculature, Am J Physiol 199I;260:R653-R662.
58. Deng A, Baylis C: Locally produced EDRF controls prcglomcrular resistance and ultrafiltration coefficient, Am J Physiol 1993:264: F212-F215.
59. Iblins JP, Palmer RMJ, Moncada S, Raij L, Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses, Am J Physiol 1990:258:H655-H662.
60. Radcrmacher J, Porstermann I, Frolich JC: Endothelium-derived relaxing factor influences renal vascular restistance, Am J Physiol 1990; 259:F9-FI7.
61. Ito S, Juncos LA, Nushiro N, Johnson CS, Carretero OA: Endothelium-derived relaxing factor modulates endothelin action in afferent arterioles, Hypertension 1991:17:1052-1056.
62. Kiyomoto H, Matsuo H, Tamaki T, Aki Y, I long II, Iwao H, Abe Y: Effect of γ-N(G)-Nitro-Ar-ginine, inhibitor of nitric synthesis, on autoregulation of renal blood flow in dogs, Jpn J Pharmacol 1992:58:147-155.
63. Majid DSA, Williams A, Navar LG: Inhibition of nitric oxide synthesis attenuates pressure-induced natriuretic responses in anesthetized dogs, Am J Physiol 1993:264:F79-F87.
64. Baumann JFL Pcrsson PB, Ehmkc H, Nal'z B, Kirchheim HR: Role of endothelium-derived relaxing factor in renal autoregulation in conscious dogs, Am J Physiol 1992:263: F208-F213.
65. Ito S, Ren Y: Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics, J Clin Invest 1993:92:1093-1098.
66. Braam B, Koomans HA: Nitric oxide antagonizes the actions of angiotensin II to enhance tubuloglomenilar feedback responsiveness, Kidney Int 1995:48:1406-1411.
67. Hackenthal E, Paul M, Ganten D, Taugner R: Morphology, physiology, and molecular biology of renin secretion, Physiol Rev 1990:70: 1067-1116.
68. Vidal MJ, Romero JC, Vanhoutte PM: Endothelium derived relaxing factor inhibits renin release, Eur J Pharmacol 1988:149:401-402.
69. Persson PB, Baumann JE, Ehmkc H, Hackenthal E, Kirchheim HR, Nafz B: Endothelium derived NO stimulates pressure-dependent renin release in conscious dogs, Am J Physiol 1993;264:F943-F947.
70. Johnson RA, Freeman RFI: Renin release in rats during blockade of nilrie oxide synthesis, Am J Physiol 1994:266:RI723-RI729.
71. Kurtz A, Kaissling B, Busse R, Baicr W: Endothelial cells modulate renin secretion from isolated mouse juxtaglomerular cells, J Clin Invest 1991:88:1147-1154.
72. Schricker K, Kurtz A: Liberators of NO exert a dual effect on renin secretion from isolated mouse renal juxtaglomerular cells, Am J Physiol 1993;265:F180-F186.
73. Greenberg SG, He X-R, Schnermann JB, Briggs JP: Effect of nitric oxide on renin secretion, I, Studies in isolated juxtaglomerular gran-ular cells, Am J Physiol 1995;268:F948-F952.
74. Scholz H, Kurtz A: Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney, J Clin Invest 1993:91:1088-1094.
75. Schricker K, Della Bruna R, Ilamann M, Kurtz A: Endothelium derived relaxing factor is involved in the pressure control of renin gene expression in the kidney, Pfliigers Arch Eur J Physiol 1994:428:261-268.
76. Kurtz A, Della Bruna R, Pfeilschifter J, Taugner R, Bauer C: Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a eGMP-mediated process, Proc Natl Acad Sci USA 1986:83:4769-4773.
77. Kurtz A, Della Bruna R, Pfeilschifter J, Bauer C: Role of cGMP as second messenger of adenosine in the inhibition of renin release, Kidney Int 1988:33:798-803.
78. Henrich WL, McAllister EA, Smith PB, Campbell WB: Guanosine 3',5’-cyclic monophosphate as a mediator of inhibition of renin release, Am J Physiol 1988:255: F474-F478.
79. Sigmon DH, Carretero OA, Beierwaltes WH: Endothelium-derived relaxing factor regulates renin release in vivo, Am J Physiol 1992:263: F256-F261.
80. Peart WS, Qucsada T, Tenyi I: The effects of cyclic adenosine 3',5'-monophosphate and guanosine 3’,5'-monophosphatc and theophylline on renin secretion in the isolated perfused kidneys of the rat, BrJ Pharmacol 1975;54:55-60.
81. Craven PA, Dcrubcrtis FR: Ca -dependent modulation of renin release from isolated glo-meru i: apparent independence from alterations incGMP, Metabolism 1985;34:651-657.
82. Muntcr K, Hackenthal E: The participation of the endothelium in the control of renin release, J Hypertens 1991;9:S236-S237.
83. Roman RJ, Zou AP: Influence of the renal medullary circulation on the control of sodium excretion, Am J Physiol 1993;265:R963-R973.
84. Majid DSA, Williams A, Kadowitz PJ, Navar LG: Renal responses to intra-artcria! administration of nitric oxide donor in dogs, Hypertension 1993:22:535-541.
85. Davis Manning R Jr., Hu L: Nitric oxide regulates renal hemodynamics and urinary sodium excretion in dogs, Hypertension 1994:23:619-625.
86. Stoos BA, Carretero OA, Parity RD, Scicli G, Garv n JL: Endothelium-derived relaxing factor inhibits transport and increases cGMP content in cultured mouse cortical collecting duct cells, J Clin Invest 1992:89:761-765.
87. Alberola A, Pinilla JM, Qucsada T, Romero JC, Salom MG, Salazar FJ: Role of nitric oxide in mediating renal response to volume expansion, Hypcrtension 1992:19:780-784.
88. Radcrmacher J, Klankc B, Schurck H, Stolte HF, Frolich JC: Importance of NO/EDRF for glomerular and tubular function: Studies in the isolated perfused rat kidney, Kidney Int 1992: 41:1549-1559.
89. De Nicola L, Blantz RC, Gabbai FB, Khang SJ: Nitric oxide and angiotensin 11: Glomerular and tubular interaction in the rat, J Clin Invest 1992; 89:1248-1256.
90. Zatz R, Denucci G: Effects of acute nitric oxide inhibition on rat glomerular microcirculation, Am J Physiol 1991:261: F360-F363.
91. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage, J Clin Invest 1992:90:278-281.
92. Cattcll V, Cook IFF: Nitric oxide: Role in the physiology and pathology of the glomerulus, Exp Nephrol 1993:1:265-280.
93. Raij L: Nitric oxide and the kidney, Circulation 1993;87(suppl 5):V26-V29.
94. Ichikawa I, Kiyama S, Yoshioka T: Renal antioxidant enzymes: Their regulation and function, Kidney Int 1994:45:1-9.
95. Ballcrmann BJ, Marsden PA: Endothelium-derived vasoactive mediators and renal glomerular function, Clin Invest Med 1991:14:508-517.
96. Ito S: Nitric oxide in the kidney, CuitOpin Nephrol Hypertens 1995:4:23-30.
97. Samuelsson Ö, Attnian PO, Knight Gibson C, Krön B, Larsson R, Mulec H, Weiss L, Alau-povic P: Lipoprotein abnormalities without hypcrlipidaemia in moderate renal insufficiency, Nephrol Dial Transplant 1994;9:I580-1585.
98. Attnian P-O, Samuelsson O, Alaupovic P: Li-poptrotein metabolism and renal failure, Am J Kidney Dis 1993:21:573-592.
99. Wanner C, Rader D, Bartens W, Krämer J, Brewer MB, Schollmeyer P, Wieland H: Elevated lipoprotcin(a) in patients with the nephrotic syndrome, Ann Intern Med 1993:119: 263-269.
100. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P: The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion, N Engl J Med 1995;332:488-493.
101. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssoncn K, Palinski W, Witztum JL: Autoantibody against oxidised LDL and progression of carotid atherosclerosis, Lancet 1992:339:883-887.
102. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man, J Clin Invest 1989;84:1086-1095.
103. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogcnicity, N Engl J Med 1989;320: 915-924.
104. Ylä-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL: Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL, Artcriosclcr Thromb 1994;14:32-40.
105. Parthasarathy S, Wieland E, Steinberg D: A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein, Proc Natl Acad Sei USA 1989:86:1046-1050.
106. Lynch SM, Frei B: Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein, J Lipid Res 1993; 34:1745-1753.
107. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH: Glycosylated low density lipoprotein is more sensitive to oxidation: Implications for the diabetic patient, Atherosclerosis 1993;102:63-67.
108. Diamond JR: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis, Kidney Int 1991;39:S29-S34.
109. Mänttäri M, Tiula E, Alikoski T, Manninen V: Effects of hypertension and dyslipidcmia on the decline in renal function, Hypertension 1995:26:670-675.
110. Sato H, Suzuki S, Ueno M, Shimada H, Kara-sawa R, Nishi S-L, Arakawa M: Localization of apolipoprotein(a) and B-100 in various renal diseases, Kidney Int 1993;43:430-435.
111. Kirschenbaum MA, Pai R, Roh DD, Kamanna VS: Role of atherogenic lipoproteins in cytokine-mediated renovascular injury, Mineral Electrolyte Metabol 1996;22:47-50.
112. Rovin BH, Tan LC: LDL stimulates mesangial fibronectin production and chemoattractant expression, Kidney Int 1993:43:218-225.
113. Giuijarro C, Keane WF: Effects of lipids on the pathogenesis of progressive renal failure: Role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in the prevention of glomerulosclerosis, Mineral Electrolyte Metabol 1996;22:147-152.
114. Lam K, Cheng P, Janus E, Pang R: Cholesterol-lowering therapy may retard the progression of diabetic nephropathy, Diabetologia 1995:38; 604-609.
115. fanner FC, Noll G, Boulanger CM, Luscher TF: Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries: Role of scavenger receptor and endothelium-derived nitric oxide, Circulation 1991;83:2012-2020.
116. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD: Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoptroteins, Nature 1990:344:160-162.
117. Galle J, Miilsch A, Busse R, Bassenge E: Effects of native and oxidized low density lipoproteins on formation and inactivation of EDRF, Artcriosclcr Thromb 1991:11:198-203.
118. Chin JH, Azhar S, Hoffmann BB: Inactivation of endothelial derived relaxing factor by oxidized lipoproteins, J Clin Invest 1992:89: 13-18.
119. Gialle J, Bengcn J, Schollmeyer P, Wanner C: Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipo-protein(a): Role of oxygen-derived radicals, Circulation 1995:92:1582-1589.
120. Galle J, Ochslcn M, Schollmeyer P, WannerC: Oxidized lipoproteins inhibit endothelium-dependent vasodilation: Effects of pressure and high-density lipoprotein, Hypertension 1994; 23:556-564.
121. Treasure CB, Klein JL, Wcintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Ccdarholm JC, Alexander RW: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary heart disease, N Engl J Med 1995:332:481-487.
122. Galle J, Stunz P, Schollmeyer P, Wanner C: Oxidized LDL and lipoprotein(a) stimulate renin release of juxtaglomerular cells, Kidney Int 1995;47:45-52.
123. Rubanyi GM, Vanhoutte PM: Superoxide anions and hypcroxia inactivate endothelium-derived relaxing factor, Am J Physiol 1986; 250:H822-H827.
124. Pryor WA, Squadrito GL: The chemistry of peroxynitrite: A product front the reaction of nitric oxide with supcroxide, Am J Physiol 1995:268: L699-L722.
125. Myers SI, Hernandez R, Castaneda A: Possible role for oxygen free radicals in the regulation of renal nitric oxide synthesis and blood flow, Am J Surg 1995; 169:604-608.
126. Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial super-oxide anion production, J Clin Invest 1993:91: 2546-2551.
127. Müggc A, Brandes RP, Böger RI I, Dwenger A, Bode-Bögcr S, Kienke S, Frölich JC, Lichtlen PR: Vascular release of superoxide radicals is enhanced in hypercholestérolémie rabbits, J Cardiovasc Pharmacol 1994:24:994-998.
128. Hansen PR, Kharazmi AK, Jauhiainen M, Ehnholm C: Induction of free radical generation in human monocytes by lipoprotein(a), Eur J Clin Invest 1994;24:497-499.
129. Krccscl M: Greiber S, Schollmeyer P, Wanner C: Lipoprotcin(a) and O,-Produktion in isolierten Glomeruli: Nieren- und Hochdruck-krankhciten 1995;24:532.
130. Esterbauer H, Jürgens G, Quehenberger O, Koller E: Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes, J Lipid Res 1987;28:495-509.
131. Witztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogenesis, J Clin Invest 1991:88:1785-1792.
132. Yokoyama M, Hi rata K, Miyake R, Akita H, Ishikawa Y, Fukuzaki II: Lysophosphatidyl-cholinc: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein, Biochcm Bio-phys Res Commun 1990; 168:301-308.
133. Liu S-Y, Lu X, Choy S, Dembinski TC, Hatch GM, Mymin D, Shen X, Angel A, Choy PC, Man RYK: Alteration of lysophosphatidylcho-line content in low density lipoprotein after oxidative modification: Relationship to endothelium dependent relaxation, Cardiovasc Res 1994;28:1476-1481.
134. Murohara T, Kugiyama K, Ohgushi M, Sugi-yama S, Ohta Y, Yasue H: LPC in oxidized LDL elicits vasocontraction anil inhibits endo-thelium-dcpcndent relaxation, AM J Physiol 1994;267: H2441-H2449.
135. Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison DG: Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation, Artcriosclcr Thromb 1994;14:1007-1013.
136. Manila RK, Buckalew VM Jr: Effect of lysophosphatidylcholine on renal hemodynamics and excretory function in anest.hetized rats, Life Sei 1992:51:1571-1575.
137. 1effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation, Circ Res 1993:72:1103-1109.
138. Galle J, Beugen J, Schollmeyer P, Wanner C: Oxidized lipoprotcin(a) inhibits endothelium-dependent dilation: Prevention by high density lipoprotein, Eur J Pharmacol 1994:265: 111-115.
139. Cialle J, Härtens W, Wanner C: High density lipoproteins prevent renin secretion from juxtaglomerular cells stimulated by oxidized LDL and Lp(a), J Am Soc Nephrol 1995:6:620.
140. Barajas L: Anatomy of the juxtaglomerular apparatus, Am J Physiol 1979:237:F333-F343.
141. Mason J: The pathophysiology of Sandimmune (cyclosporine) in man and animals, Pe-diatr Nephrol 1990;4:554-574.
142. Bunchman T, Brookshire C: Cyclosporin-induced synthesis of endothelin by cultured human endothelial cells, J Clin Invest 1991:88: 310-314.
143. Dinh-Xuan A, Fan T, Higgenbottam T, Wall-work J: Cyclosporin in vitro reduces endothelium-dependent relaxation to acetylcholine but does not affect relaxation to nitrovasodilators, Transplant Proc 1990:22:1723-1725.
144. Bossaller C, Förstermann U, Hertel R, Olbricht C, Rcschkc V, Fleck F: Ciclosporin a inhibits endothelium-dependent vasodilatation and vascular prostacyclin production, Eur J Pharmacol 1989:165:165-169.
145. Bloom ITM, Bentley FR, Spain DA, Garrison RN: An experimental study of altered nitric oxide metabolism as a mechanism of cyclosporin-induced renal vasoconstriction, Br J Surg 1995;82:195-198.
146. Gallego MJ, Garcia Villalón AL, López Farrc AJ, Garcia IL, Plácida Garrón M, Casado S, Hernando L, Caramelo CA: Mechanisms of the endothelial toxicity of cyclosporin A: Role of nitric oxide, cGMP, andCV, Circ Res 1994: 74:477-484.
147. Diederich D, Skopec J, Diederich A, Dai F-X: Cyclosporine produces endothelial dysfunction by increased production of Superoxide, Hypertension 1994:23:957-961.
148. Akita K, Dusting GJ, Hickey H: Suppression of nitric oxide production by cyclosporin A and FK506A in rat vascular smooth muscle cells, Clin Exp Pharmacol Physiol 1994:21: 231-233.
149. Hattori Y, Nakanishi N: Effects of cyclosporin A and FK506 on nitric oxide and tetrahydro-biopterin synthesis in bacterial lipopolysac-charide-trcatcd J774 macrophages, Cell Immun 1995:165:7-11.
150. Cantlcy LG, Spokes K, Clark B, Mcmahon EG, Carter J, Epstein FH: Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction, Kidney Int 1993:44: 1217-1223.
151. Schwartz D, Blum M, Peer G, Wollman Y, Maree A, Sorban I, Grosskopf I, Cabili S, Levo Y, laina A: Role of nitric oxide (EDRF) in radiocontrast acute renal failure in rats, Am,1 Physiol 1994;267: F374-F379.
152. Agmon Y, Pelcg H, Grecnfeld Z, Rosen S, Brc-zis M: Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the ral, J Clin Invest 1994:94:1069-1075.
153. Bank N, Aynedjian HS: Role of EDRF (nitric oxide) in diabetic renal hyperfiltration, Kidney Int 1993:43:1306-1312.
154. Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer SM: Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats, Role of NO, Am J Physiol 1993:265:F886-F895.
155. Bucala R, Tracey KJ, Ccrami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes, J Clin Invest 1991:87:432-438.
156. Cohen RA: Dysfunction of vascular endothelium in diabetes mellitus, Circulation 1993; 87(suppl 5):V67-V76.
157. Johnstone M I, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus, Circulation 1993;88:2510-2516.
158. Lyons TJ: Glycation and oxidation: A role in the pathogenesis of atherosclerosis, Am J Cardiol 1993:71:26B-31B.
159. Wolff SP, Dean RT: Glucose autoxidation and protein modification, Biochem J 1987:245: 243-250.
160. Kawamura M, Hcincckc JW, Chait A: Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a supcroxide-dcpendent pathway, J Clin Invest 1994:94:771-778.
161. Ohishi K, Carolines PK: Superoxide dismuta-se restores the influence of nitric oxide on renal arterioles in diabetes mellitus, J Am Soc Nephrol 1995:5:1559-1566.
162. Bucala R, Makita Z, Vega G, Grundy S, Ko-schinsky T, Ccrami A, Vlassara H: Modification of low density lipoprotein by advanced glycation end products contributes to the dys-lipidemia of diabetes anti renal insufficiency, Proc Natl Acad Sei USA 1994:91:9441- 9445.
163. Liischer T, Raij L, Vanhoutte PM: Endothelium-dependent vascular responses in normo-tensive and hypertensive Dahl rats, Hypertension 1987;9:157-163.
164. Linder L, Kiowski W, Bühler FR, Löscher TF: Indirect ev idence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in essential hypertension, Circulation 1990:81: 1762-1767.
165. Panza JA, Quyyumi AA, Brush, IE, Epstein SE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension, N Engl J Med 1990:323:22-27.
166. Treasure CB, Manoukian SV, Klein JL, Vita JA, Nabel EG; Remvick GH, Selwyn AP, Alexander RW, Ganz P: Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients, Circ Res 1992:71:776-781.
167. Matlson DE, Lu S, Nakanishi K, Papanck PE, Cowley AW Jr.: Effect of chronic renal medullary nitric oxide inhibition on blood pressure, Am J Physiol 1994:266: H1918-H1926.
168. Salazar FJ, Alberola A, Pinilla JM, Romero JC, Quesada T: Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition, Hypertension 1993:22:49-55.
169. Lahera V, Salazar J, Salom MG, Romero JC: Deficient production of nitric oxide induces volume-dependent hypertension, J Hypcrtcns 1992; 1 (suppl 7):S173-S177.
170. Nakamura T, Alberola AM, Granger JP: Role of renal interstitial pressure as a mediator of sodium retention during systemic blockade of nitric oxide, Hypertension 1993:21:956-960.
171. Chen PY, Sanders PW: α-Arginine abrogates salt-sensitive hypertension in dahl/rapp rats, J Clin Invest 1991;88:1559-1567.
172. Chen PY, Sanders PW: Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl Rapp rats, Hypertension 1993:22:812-818.
173. Pfciischifter J, Kunz D, Mühl II: Nitric oxide: An inflammatory mediator of glomerular mesangial cells, Nephron 1993:64:518-525.
174. Cattell V, Eianos E, I, argen P, CookT: Glomerular NO synthase activity in mesangial cell immune injury, Exp Nephrol 1993:1:36-40.
175. Shultz PJ, Raij L: Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis, J Clin Invest 1992:90: 1718-1725.
176. Halliwell B: The role of oxygen radicals in human disease, with particular reference to the vascular system, Haemostasis 1993;23 (suppl 1): 118 126.
177. Darlcy-Usmar V, Wiseman H, Halliwell B: Nitric oxide and oxygen radicals: A question of balance, FEBS Let 1995;369:131-135.
178. Schramm E, Heidbreder E, Lopau K, Schaar J, Zimmermann J, Harlos J, Teschner M, Ling H, Ileidland A: Influence of nitric oxide on renal function in toxic acute renal failure in the rat, Mineral Electrolyte Metabol 1996:22:168-177.
179. Schramm L, Heidbreder E, Schmitt A, Karlen-bender K, Zimmermann J, Ling H, Heidland A: Role of ¿-arginine-derived NO in ischemic acute renal failure in the rat, Renal Fail 1994: 16:555-569.
180. Vallance P, Leone A, Calvcr A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure, Lancet 1992:339:572-575.